×

Pharma companies navigating 'patent cliffs'

8:15 AM ET Mon, 29 July 2013

Barbara Ryan, FTI Consulting, provides a preview of Pfizer and Merck's earnings, and discusses how both pharma giants have improved shareholder value through M&A.